These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15104204)

  • 1. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications.
    Basu S
    Antioxid Redox Signal; 2008 Aug; 10(8):1405-34. PubMed ID: 18522490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F2-isoprostanes as markers of oxidative stress in vivo: an overview.
    Milne GL; Musiek ES; Morrow JD
    Biomarkers; 2005 Nov; 10 Suppl 1():S10-23. PubMed ID: 16298907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F2-isoprostanes as markers of oxidant stress: an overview.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.5. PubMed ID: 23045114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. F2-isoprostanes as biomarkers of lipid peroxidation in patients with chronic renal failure.
    Wiswedel I; Hirsch D; Carluccio F; Hampl H; Siems W
    Biofactors; 2005; 24(1-4):201-8. PubMed ID: 16403981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive eicosanoids: role of prostaglandin F(2α) and F₂-isoprostanes in inflammation and oxidative stress related pathology.
    Basu S
    Mol Cells; 2010 Nov; 30(5):383-91. PubMed ID: 21113821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
    Patrono C; FitzGerald GA
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2309-15. PubMed ID: 9409197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress.
    Musiek ES; Morrow JD
    Curr Protoc Toxicol; 2005 Jun; Chapter 17():Unit 17.6. PubMed ID: 23045115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues.
    Halliwell B; Lee CY
    Antioxid Redox Signal; 2010 Jul; 13(2):145-56. PubMed ID: 20001743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients.
    Basu S
    Toxicology; 2003 Jul; 189(1-2):113-27. PubMed ID: 12821287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
    Kadiiska MB; Gladen BC; Baird DD; Graham LB; Parker CE; Ames BN; Basu S; Fitzgerald GA; Lawson JA; Marnett LJ; Morrow JD; Murray DM; Plastaras J; Roberts LJ; Rokach J; Shigenaga MK; Sun J; Walter PB; Tomer KB; Barrett JC; Mason RP
    Free Radic Biol Med; 2005 Mar; 38(6):711-8. PubMed ID: 15721981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of F2-isoprostanes as a biomarker of oxidative stress.
    Milne GL; Sanchez SC; Musiek ES; Morrow JD
    Nat Protoc; 2007; 2(1):221-6. PubMed ID: 17401357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.